Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical versus systemic tranexamic acid in pediatric cardiac surgery
IRCT20170316033099N11Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of tranexamic acid in Cardiovascular Malformation (CVM) (3 arms), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Primary endpoints: Bleeding volume and Need for blood products. Started Jan 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on IRCT20170316033099N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170316033099N11.